Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EKF Diagnostics HoldingsEKDHF 54 Return-on-Tangible-Equity is 0.84% as of Dec. 2025, which is 94% below its 10-year median of 14.52. GuruFocus rates EKDHF with a GF Scoreâ„¢ of 54/100 and a GF Valueâ„¢ of $0.36 (Fairly Valued). The stock has 4 warning signs investors should review. Among 758 Medical Devices & Instruments companies, EKF Diagnostics Holdings ranks better than 52.37% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. EKF Diagnostics Holdings's annualized net income for the quarter that ended in Dec. 2025 was $0.48 Mil. EKF Diagnostics Holdings's average shareholder tangible equity for the quarter that ended in Dec. 2025 was $56.69 Mil. Therefore, EKF Diagnostics Holdings's annualized Return-on-Tangible-Equity for the quarter that ended in Dec. 2025 was 0.84%.
The historical rank and industry rank for EKF Diagnostics Holdings's Return-on-Tangible-Equity or its related term are showing as below:
EKDHF'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -22.01 Med: 14.52 Max: 53.03
Current: 4.99
During the past 13 years, EKF Diagnostics Holdings's highest Return-on-Tangible-Equity was 53.03%. The lowest was -22.01%. And the median was 14.52%.
EKDHF's Return-on-Tangible-Equity is ranked better than 52.37% of 758
companies
in the Medical Devices & Instruments industry
Industry Median: 4.055
vs EKDHF: 4.99
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
EKF Diagnostics Holdings Return-on-Tangible-Equity Related Terms
EKF Diagnostics Holdings Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for EKF Diagnostics Holdings's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EKDHF vs ABT, SYK, MDT: Return-on-Tangible-Equity Comparison
For the Medical Devices subindustry, EKF Diagnostics Holdings's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
EKF Diagnostics Holdings Return-on-Tangible-Equity vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, EKF Diagnostics Holdings's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where EKF Diagnostics Holdings's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is two times the semi-annual (Dec. 2025) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 0.84% mean?
EKF Diagnostics Holdings (EKDHF) has a Return-on-Tangible-Equity of 0.84% as of Dec. 2025. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on EKF Diagnostics Holdings and its competitors. This is 94% below median its historical median of 14.52. According to the industry distribution chart, EKF Diagnostics Holdings ranks #361 out of 758 companies in the Medical Devices & Instruments industry, placing it in the top 47.6%.
Is EKF Diagnostics Holdings' Return-on-Tangible-Equity too high?
EKF Diagnostics Holdings' current Return-on-Tangible-Equity of 0.84% is 94% below median its 10-year median of 14.52. The Medical Devices & Instruments industry median Return-on-Tangible-Equity is 4.06. EKF Diagnostics Holdings' value of 0.84% is 79.3% below this industry median. Based on the distribution chart, EKF Diagnostics Holdings ranks #361 out of 758 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, EKF Diagnostics Holdings has a GF Scoreâ„¢ of 54/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does EKF Diagnostics Holdings' Return-on-Tangible-Equity compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, EKF Diagnostics Holdings ranks #361 out of 758 companies for Return-on-Tangible-Equity. This puts EKF Diagnostics Holdings in the upper half of its industry. The industry median Return-on-Tangible-Equity is 4.06. EKF Diagnostics Holdings' value of 0.84% is 79.3% below this benchmark. While the company's 10-year median is 14.52 vs. the industry median of 4.06, EKF Diagnostics Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Medical Devices & Instruments company?
The median Return-on-Tangible-Equity among Medical Devices & Instruments companies is 4.06, based on 758 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. EKF Diagnostics Holdings's current Return-on-Tangible-Equity of 0.84% is 79.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on EKF Diagnostics Holdings and its competitors. For the Medical Devices & Instruments industry, the median Return-on-Tangible-Equity is 4.06 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. EKF Diagnostics Holdings's current Return-on-Tangible-Equity is 0.84%, which is 94% below median its own 10-year median of 14.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EKF Diagnostics Holdings stock overvalued right now?
Based on GuruFocus' analysis, EKF Diagnostics Holdings (EKDHF) is currently considered Fairly Valued. The stock's GF Value™ is $0.36, compared to a current price of $0.35 — trading 3.6% below its estimated fair value. The current Return-on-Tangible-Equity is 0.84%, which is 94% below median its 10-year median of 14.52 and 79.3% below the Medical Devices & Instruments industry median of 4.06. EKF Diagnostics Holdings' overall GF Score™ is 54/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For EKF Diagnostics Holdings (EKDHF), the current Return-on-Tangible-Equity is 0.84% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is EKF Diagnostics Holdings (EKDHF) Overvalued in 2026?
Based on GuruFocus' analysis, EKF Diagnostics Holdings stock appears to be undervalued.
The current stock price of $0.35 is trading 3.6% below its estimated GF Value™ of $0.36.
GuruFocus considers EKF Diagnostics Holdings to be Fairly Valued.
Key valuation signals for EKDHF:
Return-on-Tangible-Equity: 0.84% (94% below median its 10-year median of 14.52)
GF Value™: $0.36 vs. price of $0.35 (3.6% below fair value)
Industry Position: 79.3% below the Medical Devices & Instruments median (#361 of 758)
No single metric tells the full story. See the EKDHF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
EKF Diagnostics Holdings PLC is engaged in development, manufacture and supply of products and services into the in-vitro diagnostic (IVD) market place. The Group has presence in the UK, USA, Germany, and Russia, and sells throughout the world including Europe, the Middle East, the Americas, Asia, and Africa. It derive their revenue from the manufacture and sale of medical diagnostic equipment and reagents. Other services include the servicing and distribution of third party company products under separate distribution agreements.
54GF Score
Get the complete analysis for EKDHF
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
EKDHF has been successfully added to your 
